NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — The Nasdaq (Nasdaq: NDAQ) today announced that Enphase Energy, Inc. (Nasdaq: ENPH) will become a constituent of the NASDAQ-100 Index® (Nasdaq: NDX) and the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) before market open on Monday, November 21, 2022. Enphase Energy, Inc. will replace Okta, Inc. (Nasdaq: OKTA) in the NASDAQ- 100 clue® and the equally weighted NASDAQ-100 index. Okta, Inc. will also be removed from the NASDAQ-100 Technology Sector Index (Nasdaq: NDXT) and the NASDAQ-100 Technology Sector Market-Cap Weighted Index (Nasdaq: NDXTMC) before market open on Monday. November 21, 2022. Enphase Energy, Inc. will be considered for inclusion in the NASDAQ-100 Ex-Technology Index (Nasdaq: NDXX) at the next quarterly rebalance.
For more information about the company, visit https://enphase.com/.
About the Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us at LinkedInon Twitter @Nasdaqor at www.nasdaq.com.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, whether on behalf of a particular financial product or of an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or make any statement about the financial condition of any company or fund. Statements regarding proprietary Nasdaq indices are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance does not represent future results. Investors should undertake their own due diligence and carefully assess companies before investing. THE ADVICE OF A PROFESSIONAL IN SECURITIES IS STRONGLY RECOMMENDED.
NDAQG
|
Media Contact: |
Camille Stafford, Nasdaq |
|
|
Issuer and investor contact: |
Index Customer Services, Nasdaq |
|
Comments are closed.